HDL action on the vascular wall: Is the answer NO?

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study (see the related article beginning on page 569) shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

Original languageEnglish (US)
Pages (from-to)509-513
Number of pages5
JournalJournal of Clinical Investigation
Volume113
Issue number4
DOIs
StatePublished - Feb 2004

Fingerprint

Lysophospholipids
Vascular Endothelium
HDL Cholesterol
Blood Vessels
Atherosclerosis
Incidence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

HDL action on the vascular wall : Is the answer NO? / Shaul, Philip W.; Mineo, Chieko.

In: Journal of Clinical Investigation, Vol. 113, No. 4, 02.2004, p. 509-513.

Research output: Contribution to journalArticle

@article{adbf748452974cffb9c11b080b508d12,
title = "HDL action on the vascular wall: Is the answer NO?",
abstract = "Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study (see the related article beginning on page 569) shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.",
author = "Shaul, {Philip W.} and Chieko Mineo",
year = "2004",
month = "2",
doi = "10.1172/JCI200421072",
language = "English (US)",
volume = "113",
pages = "509--513",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

TY - JOUR

T1 - HDL action on the vascular wall

T2 - Is the answer NO?

AU - Shaul, Philip W.

AU - Mineo, Chieko

PY - 2004/2

Y1 - 2004/2

N2 - Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study (see the related article beginning on page 569) shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

AB - Circulating levels of HDL cholesterol are inversely related to the risk of atherosclerosis, and therapeutic increases in HDL reduce the incidence of cardiovascular events. A new study (see the related article beginning on page 569) shows that HDL-associated lysophospholipids stimulate the production of the potent antiatherogenic signaling molecule NO by the vascular endothelium.

UR - http://www.scopus.com/inward/record.url?scp=1642416885&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642416885&partnerID=8YFLogxK

U2 - 10.1172/JCI200421072

DO - 10.1172/JCI200421072

M3 - Article

C2 - 14966559

AN - SCOPUS:1642416885

VL - 113

SP - 509

EP - 513

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -